Transposon mutagenesis screen in mice identifies TM9SF2 as a novel colorectal cancer oncogene

Christopher R Clark1, Makayla Maile1, Patrick Blaney1

  • 1Department of Obstetrics, Gynecology and Women's Health, University of Minnesota, Minneapolis, MN, USA.

Scientific Reports
|October 19, 2018
PubMed

Insights

Transmembrane 9 Superfamily 2 (TM9SF2) is identified as a novel oncogene driving colorectal cancer (CRC) progression. Targeting TM9SF2 may offer new therapeutic strategies for advanced CRC patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Advanced colorectal cancer (CRC) requires novel therapeutic targets.
  • The Transmembrane 9 Superfamily (TM9SF) protein family is conserved but understudied.
  • Insertional mutagenesis screens can identify novel cancer driver genes.

Purpose of the Study:

  • To identify and characterize novel therapeutic targets for advanced colorectal cancer.
  • To define the role of Transmembrane 9 Superfamily 2 (TM9SF2) as a potential oncogene in CRC.

Main Methods:

  • Conducted an insertional mutagenesis screen in mice to identify CRC driver genes.
  • Analyzed The Cancer Genome Atlas (TCGA) and independent CRC patient samples for TM9SF2 expression.
  • Utilized RNA interference (RNAi) and CRISPR/Cas9 gene editing to assess TM9SF2 function.
  • Performed transcriptome analysis to investigate TM9SF2's molecular pathways.

Main Results:

  • TM9SF2 was identified as a novel CRC oncogene and a candidate progression driver.
  • Elevated TM9SF2 mRNA levels were found in approximately 35% of CRC patients.
  • TM9SF2 silencing or knockout reduced CRC cell growth and tumor fitness in vitro and in vivo.
  • TM9SF2 influences cell cycle, oxidative phosphorylation, and ceramide signaling pathways.
  • Increased TM9SF2 expression correlates with advanced disease stage and poorer relapse-free survival.

Conclusions:

  • TM9SF2 is a novel oncogene that promotes colorectal cancer progression.
  • TM9SF2 represents a potential therapeutic target for advanced CRC.
  • Further investigation into TM9SF2's role in cancer biology is warranted.

Related Concept Videos

DNA-only Transposons02:57

DNA-only Transposons

DNA-only transposons are called autonomous transposons since they code for the enzyme transposase that is required for the transposition mechanism. Insertion of transposons can alter gene functions in multiple ways. They can mutate the gene, alter gene expression by introducing a novel promoter or insulator sequence, introduce new splice sites, and change the mRNA transcripts produced, or remodel chromatin structure.
The donor site from where the transposon is excised is either degraded or...
17.5K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.5K
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
16.3K
Transposons01:24

Transposons

Transposons, or "jumping genes," are small mobile genetic elements (MGEs) that range from 700 to 40,000 base pairs in length. They are found in all organisms and can move within the same chromosome or transfer to different chromosomes. In some cases, transposons can also jump between different host DNA molecules, such as plasmids or viruses, contributing to genetic variability.Barbara McClintock first discovered these mobile genetic elements in the 1940s while studying maize genetics, and she...
1.9K
Identifying Statistically Significant Differences: The F-Test01:14

Identifying Statistically Significant Differences: The F-Test

The F-test is used to compare two sample variances to each other or compare the sample variance to the population variance. It is used to decide whether an indeterminate error can explain the difference in their values. The underlying assumptions that allow the use of the F-test include the data set or sets are normally distributed, and the data sets are independent of each other. The test statistic F is calculated by dividing one variance by another. In other words, the square of one standard...
3.8K
Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.7K